Important Selected Product Safety Information

CUTIVATE^® LOTION is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation (please see accompanying full prescribing information).

The safety and efficacy of CUTIVATE^® LOTION in pediatric patients below 1 year of age have not been established.

CUTIVATE^® LOTION should not be used in individuals with hypersensitivity to formaldehyde.

Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal from treatment. Manifestations of Cushing's syndrome, hyperglycemia, and glucosuria can also be produced in some patients by systemic absorption of topical corticosteroids while on treatment.

The following local adverse reactions have been reported with topical corticosteroids such as irritation, folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, hypertrichosis, and miliaria.

CUTIVATE^® LOTION should not be used where infection is present at the treatment site.

Patients should avoid excessive exposure to either natural or artificial sunlight (including tanning booths, sun lamps, etc.).

Please see link to full prescribing information below.

CUTIVATE^® (fluticasone propionate) LOTION Full Prescribing Information